Video

Challenges in clinical trial execution for Live Biotherapeutics

An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…

AI implementation for microbiome small molecule discovery & therapeutics

Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.

Why microbiome therapies are the next frontier in oncology

Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.

Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health

Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.

Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…

The role of gut microbiota and mycobiota in pre-eclampsia

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.

IBS DAYS 2024 in Bologna with experts from all over the world 

Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.

Don’t miss the 10th International Human Microbiome Consortium (IHMC) Congress 2024

Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.

How physical activities shape our gut microbiome

Silvia Barbaresi, molecular biologist, researcher and nutritionist at Ghent Univerity, discusses how sports and physical activity in general impact on gut microbiota composition.

Unraveling the gut microbiome’s role in celiac disease pathogenesis

Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top